Clearly, a company looking to evade responsibility of long-term effects is an admission there is a non-negligible risk. And weighed against personal risk, at least in the US, it makes sense for a lot of people to not even take the long-term gamble to potentially save an 85-year-old.

Maybe tons of people if not the majority don’t care or would happily take the vaccine - let them!

But it seems far too short-sighted to discount all the people that wouldn’t want to take an incredibly quickly developed vaccine (with debated and unproven benefit - does it provide immunity? how long?) for a disease that seems mild for most people.

This is much less clear cut than you’re letting on, while being obstinate about data which we don’t have.